Back
HFA Premium Access

Calcium channel blocker and outcomes in patients with heart failure and mildly reduced or preserved ejection fraction

Session: Chronic heart failure - treatment 3
Topic: Pharmacotherapy
Speaker: Doctor S. Matsumoto (Tokyo, JP)
Event: Heart Failure 2023

Congress Presentation

Add to my library

Like

About the speaker

Doctor Shingo Matsumoto

Toho University, Tokyo (Japan)
0 follower

4 more presentations in this session

Efficacy of dapagliflozin according to heart rate in patients with heart failure: a patient-level pooled analysis of DAPA-HF and DELIVER

Speaker: Doctor T. Kondo (Glasgow, GB)

Access
Abstract
Slides
Like
Thumbnail

Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial

Speaker: Doctor T. Kondo (Glasgow, GB)

Access
Abstract
Slides
Like
Thumbnail

Medium term improvement in left ventricular systolic function following CRT pacemaker implantation indicates additional defibrillator component may not be necessary

Speaker: Doctor H. Shabbir (Blackburn, GB)

Access
Abstract
Slides
Like
Thumbnail

Left bundle branch block cardiomyopathy: an intriguing and defiant entity from diagnosis to treatment

Speaker: Ms C. Oliveira (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Chronic heart failure - treatment 3

Speakers: Doctor S. Matsumoto, Doctor T. Kondo, Doctor T. Kondo, Doctor H. Shabbir, Ms C. Oliveira
Access
Like
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources